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Abstract
Background: Transgenic (tg) mice with chronic
overexpression of the human erythropoietin gene are
characterized by an increased hematocrit of about
0.80 in adulthood. This is accompanied by cardiac
dysfunction and premature death. The aim of this
study was to examine whether this cardiac dysfunction
was accompanied by hypertrophy of the heart with
remodeling of the extracellular matrix (ECM). Methods:
3-months-old wild type (wt) and tg mice without
cardiac hypertrophy were compared with the
respective 7-months-old mice. The mRNA of brain
natriuretic peptide (BNP), of the matrix
metalloproteinases (MMP)-2, -8, -9, -13, of the tissue
inhibitor of metalloproteinase (TIMP)-1, -2, -3, -4 and
of collagen I and III  was detected by ribonuclease
protection assay. The activity of MMPs was measured
by zymography. Results: There was hypertrophy of
both ventricles in 7-months-old tg mice, which was
accompanied by elevated mRNA expression of BNP.
MMP-2 activity was increased and MMP-9 activity was
decreased in the left ventricle (LV) of 3-months-old
tg mice. This was accompanied by elevated TIMP-4
expression, followed by a shift of collagen mRNA
expression from type III to type I in this ventricle.
Conclusion: The shift to collagen I in the heart of tg
mice might be associated with a stiffer ventricle
resulting in diastolic dysfunction. This may be
responsible for a relative and intermittent LV- and right
ventricle (RV)-insufficiency which was likely to have
occurred as evidenced by the elevation of lung and
liver weight with hemorrhage and interstitial fibrosis
after 7 months.
Introduction
Erythrocytosis is characterized by an increased
number of red cells in the peripheral blood. This form of
polycythemia has been classified as primary
erythrocytosis with truncation of the erythropoietin (EPO)
receptor or polycythemia vera, as secondary  and as
idiopathic erythrocytosis [1]. There are congenital
secondary forms of erythrocytosis such as high oxygen
affinity hemoglobin or autonomous high EPO production
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and acquired secondary erythrocytosis by hypoxia or renal
disease. Erythrocytosis has been regarded as one of the
conditions in which hyperviscosity of the blood occurs.
Under physiological conditions, the hyperviscosity state
does not present a rheological problem, although platelet-
vessel wall interactions are enhanced [2]. However, when
circulatory adaptations in various types of erythrocytosis
are limited or when general circulatory disturbances occur,
blood hyperviscosity plays a critical role in reducing flow
and causing ischemia and tissue damage.
Recently, a transgenic mouse line (EPO-tg6) has
been generated that constitutively overexpresses the
human EPO cDNA in an oxygen-independent manner
[3]. This tg mice show excessive erythrocytosis with
hematocrit values of 0.80. EPO is a 30.4 kDa glycoprotein
that regulates red cell production [4]. In humans,
peritubular cells in the adult kidney and hepatocytes in
the fetus produce EPO. EPO binds to an erythroid
progenitor cell surface receptor and acts primarily to
rescue erythroid cells from apoptosis to increase their
survival. EPO acts synergistically with several growth
factors to cause maturation and proliferation of erythroid
progenitor cells. This leads to hypoxia-mediated
erythrocytosis with elevated hematocrit especially in high-
altitude residents [5]. Adult EPO-tg6 animals do not
develop hypertension or thromboembolic complications,
a common reason for occlusive complications in
erythrocytoses [6]. The expected rise in blood pressure
and cardiovascular complications are prevented by a
pronounced increase in NO bioavailability [3], and
regulated elevation of blood viscosity is counteracted by
increasing erythrocyte flexibility [7] in these animals.
However, it has also been shown that the endothelin
system is activated in these tg mice, suggesting an
impairment of vasoactive mechanisms [8].
It has been demonstrated recently that the
erythrocytosis-induced elevation of hematocrit leads to
cardiac dysfunction with strongly reduced endurance upon
exercise and to premature death [9]. However, there was
no difference in heart function under baseline resting
conditions [10]. The reduced exercise-endurance could
be explained by acute heart failure since norepinephrine
infusion in EPO-tg6 mice led to myocardial ischemia with
diastolic dysfunction [10]. The hearts of tg mice were
hypertrophied [9, 10]. Hypertrophy of the heart is often
associated with cardiac fibrosis [11].
It was the aim of this study to investigate whether
hypertrophy of the heart in EPO-tg6 mice is associated
with cardiac fibrosis. Therefore extracellular matrix
(ECM) remodeling was characterized by the analysis of
the expression of collagen I and III, main components of
the ECM, and the mRNA expression and activity of
collagen degradation enzymes, the matrix
metalloproteinases (MMP’s) and their inhibitors
(TIMP’s). In addition, lung and liver were analyzed
histologically and immunohistochemically for possible
manifestations of the consequences of heart failure.
Materials and Methods
Animals
The transgenic mouse line termed tg6 carries the human
erythropoietin (EPO) cDNA driven by the platelet-derived
growth factor β (PDGF-β) promoter as described earlier [3].
The transgene is inherited as an autosomal dominant trait.
Hemizygous transgenic (tg) males were mated to wild-type (wt)
C57Bl/6 females, and the wt littermates served as controls in all
experiments. 3 months old mice (wt: n = 5, tg: n = 5) were
compared with 7 months old mice (wt: n = 19, tg: n = 18) The
animals were maintained in accordance with the Guide for Care
and Use of Laboratory Animals published by the US National
Institute of Health (NIH Publication No. 85-23, revised 1996).
They were allowed to move freely in their cages with access to
tap water and standard chow diet (Altromin C 100, Altromin
GmbH, Lage, Germany), ad libitum.
The hearts were rapidly excised from the anesthetized
animal (Trapanal 100 mg/kg i.p., Byk Gulden). The RV free wall
was trimmed away. Both ventricles were weighed after freezing
in liquid nitrogen. Lung and liver were excised, weighed, one
part each was fixed in 4% buffered formaldehyde, and the other
part was frozen in liquid nitrogen. Lung specimens of 9 animals
were dried for 10 hours at 95°C. In these lung samples, the wet-
to-dry weight ratio was determined as an indicator of potential
edema.
Histological analysis
In another series, the hearts of  7 months old mice
(wt: n = 5, tg: n = 5) were excised and fixed in 4% buffered
formaldehyde, embedded in paraffin, and 5 µm sections were
stained with hematoxylin-eosin (HE), PAS (periodic acid Schiff)
and Sirius red (0.5% in saturated aqueous picric acid). The
sections were quantified morphometrically with a computer-
assisted image analysis system (VIDAS 25, Zeiss, Germany)
[12]. Collagen quantification was performed under a microscope
fitted with cross-polarization filters by analyzing sections
stained with Sirius red using the VIDAS system. Under
polarization microscopy the collagen fibers which had been
stained with Sirius red luminated in green or red-yellow colors.
Cardiac fibrosis can be quantified due to these birefringent
properties of fibrillar collagen.
The fixed and paraffin-embedded lung and liver samples
were sectioned in 7 µm slices and stained with HE. The
immunohistochemical analysis was performed as described
recently [13]. For the immunohistochemical visualization of
collagen Type I, III and IV, the following antibodies were used:
collagen Type I: Batch 363205 (Quartett, Berlin, GERMANY);
Briest/Homagk/Baba/Deten/Raßler/Tannapfel/Wagner/Wenger/ZimmerCell Physiol Biochem 2004;14:277-284
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dil.: 1:50; collagen Type III: Clone HWD 1.1 (BioGenex,
Hamburg, GERMANY); dil.: 1:100; collagen Type IV: Clone
CIV22 (DAKO, Hamburg, GERMANY); dil.: 1:100. The
reactivity of the antibodies was tested using sections of tissue
with known positive reactivity in each batch. Negative controls
were also performed by replacing the primary antibody with
goat ascites fluid (Sigma-Aldrich Biochemicals, St. Louis, MO).
In all cases, liver and lung tissue from tg and wt animals was
used. The staining of the sections was evaluated by an expert
pathologist to rate the severity of histological changes without
the knowledge which section was from wt or tg animal. The
description of the histological changes represents the
characteristic features of all preparations. For presentation, we
chose typical examples, which were observed in all slices of
the same subgroup.
RNase Protection Assay
Total RNA was isolated using TRIZOLTM reagent
(InvitrogenTM, Karlsruhe, Germany) according to the
manufacturer’s protocol. 2.5 or 7.5 µg of total RNA were used
in the RNase protection assay (RPA) with the probe template
mECM1 or mECM2, respectively, labeled with RiboQuant In
Vitro Transcription Kit (Pharmingen, Hamburg, Germany; final
probe concentration: 4x105 cpm/µl) and [α-32P] UTP (3000 Ci/
mmol, Amersham, Freiburg, Germany), as described by the
manufacturer. After hybridization (56°C; 12-16 h), the
unhybridized riboprobe was digested with a mixture of RNases
A and T1 (RiboQuant RPA Kit, Pharmingen, Hamburg,
Germany), according to the manufacturer’s instructions.
Protected probes were displayed by electrophoresis on a
denaturing gel containing 5% polyacrylamide/8 M urea,
followed by visualization with the Molecular Imager (BioRad,
München, Germany). The densitometric quantification of the
individual bands of the RPA assays was performed by the Multi-
Analyst program version 1.1 (BioRad, München, Germany).
The probe template set mouse ECM number 1 and 2 (mECM1
and 2) were used. These contained the following mouse cDNA
(probe length in bp/protected; GenBank Accession No.,
position). mECM1: CNP (432/380; NM_010933, 136-515), BNP
(392/343; NM_008726, 1-343), colligin (350/306; NM_009825,
1016-1321), collagen I (250/200; U08020, 1914-2113), collagen
III (200/149; X52046, 999-1147), L32 (165/113; M35397, 208-321)
and GAPDH (150/96; NM_008084, 225-320);
mECM2: MMP-9 (480/430; S67830, 834-1263), MMP-2
(430/386; NM_008610, 432-817), TIMP-2 (390/341; NM_011594,
274-614), MMP-8 (325/274; NM_008611, 159-433), MMP-13
(290/240; NM_008607, 582-821),  TIMP-3 (250/198; NM_011595,
355-552), TIMP-1 (215/160; NM_011593, 148-307), TIMP-4 (190/
136; AF282730, 535-670), L32 and GAPDH as mentioned above.
These cDNA probes were generated by RT-PCR essentially as
previously described [14].
Preparation of cardiac tissue extract and zymography
Extracellular proteins of approximately 25 mg frozen tissue
were extracted with 20-fold volume of extraction buffer (10 mM
Tris-Cl pH 7.5, 150 mM NaCl, 20 mM CaCl2, 1 µM ZnSO4, 0.01%
(v/v) Triton X-100, 1.5 mM NaN3, 0.5% PMSF) over night at
4°C. These protein extracts contained approximately 1.5 mg/ml
protein (BioRad Protein assay, BioRad, München, Germany).
Myocardial matrix metalloproteinase activity in the gel was
measured as previously described [15].
Statistical analysis
All data were analyzed and expressed as mean ± S.E.M. A
multiple-sample comparison (ANOVA and multiple range test
using the criterion of the least significant differences) was
applied to test the differences between appropriate groups for
significance. A value of p < 0.05 was considered to be significant.
The program Statgraphics plus 4.1 (Statistical Graphics Corp.)
was used for all statistical calculations.
Results
Heart
The ventricle weight/body weight (VW/BW) ratio,
a macroscopic index of hypertrophy, of both ventricles
was elevated in 7-months-old tg mice (Fig. 1A). Because
increases in the expression of brain natriuretic peptide
(BNP) gene is a marker of hypertrophy, we used RPA to
quantify changes in BNP gene expression in wt and tg
mouse hearts. BNP mRNA expression was elevated in
tg animals at 7 months (Fig. 1B). The expression level of
BNP was higher in the LV than in the RV in wild type
and tg mice (Fig. 1B).
Hypertrophy of the heart requires remodeling of the
ECM. Pathological remodeling leads to fibrosis with
elevated expression of collagen and its deposition in the
majority of experimental models. The collagen I
expression tended to be increased in the LV and to be
decreased in the RV of wt and tg mice both at 3 and 7
months (Fig. 2A). The collagen III mRNA expression
was unchanged in the LV and decreased in the RV in 7-
months-old wt and tg mice (Fig. 2B). The collagen type
I/type III ratio was increased in the LV of 7-months-old
tg animals (Fig. 2C). The prevalence of collagen I could
have resulted in a stiffer heart, since collagen I is
responsible for the formation of collagen fibers. There
was a positive correlation between the expression of BNP
and of collagen I in the LV of tg mice (Fig. 3).
To analyze the potential remodeling process of ECM,
the MMP-2 and MMP-9 gelatinolytic activity was
measured. There was an increase of MMP-2 activity
and a slight decrease of MMP-9 activity in the LV of 3-
months-old tg mice (Fig. 4A). The mRNA level of MMP-
8 and MMP-13 was not detectable with 7.5 µg of total
RNA of cardiac tissue. The MMP-9 signal was very
weak. Therefore it was not possible to give a ratio to
GAPDH. The mRNA expression of MMP-2 was not
changed in both ventricles in wt and in tg mice (Tab. 1).
Erythrocytosis induced cardiac remodeling Cell Physiol Biochem 2004;14:277-284
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Fig. 2. Collagen type I (A) and type III (B) mRNA
in the left (LV) and right (RV) ventricle in
transgenic (tg) mice in comparison to wild type
(wt) after 3 and 7 months, respectively. RNA was
subjected to RNase protection assay. Data are
given as mRNA abundance relative to GAPDH
mRNA expression. C) The relative increase of
collagen I mRNA in the LV of 7-months-old tg
mice was shown by the increase in the collagen
type I to type III ratio. Means ± S.E.M.; * P < 0.05
vs. the time-corresponding wt; † P < 0.05 vs. RV;
‡ P < 0.05 vs. corresponding 3 months results;
number of measurements in parentheses (first
for LV/second for RV).
Fig. 3. The mRNA content
of collagen I in the left
ventricle of 3 months old
(open squares) and 7
months old (filled squares)
transgenic mice in
correlation to the mRNA
content of brain natriuretic
peptide (BNP). The data
were analysed with the
double reciprocal model
with a R-squared value of
47.6%: collagen I = 1/(0.019
+ 8.124/BNP).
Fig. 1. Development
of left ventricular (LV)
and right ventricular
(RV) hypertrophy in
erythropoietin over-
expressing transgenic
(tg) mice. A) Ventri-
cular weight (VW)
relative to body
weight (BW) of tg
mice in relation to wild
type (wt) controls
after 3 and 7 months
of age. Data are
expressed as per cent
of time-corresponding
wt. B) The mRNA of
the brain natriuretic
peptide (BNP) related
to the mRNA of
GAPDH. Means ±
S.E.M.; * P < 0.05 vs.
the time-correspon-
ding wt; † P < 0.05 vs.
RV; ‡ P < 0.05 vs. cor-
responding 3 months
results; number of
measurements in pa-
rentheses (first for LV/
second for RV in B).
TIMP-1 mRNA was not detectable. For all
detectable TIMPs, there was a slightly higher expression
rate in the RV than in the LV especially in wt controls
(Tab. 1). This higher expression level was significant for
TIMP-3 in 7-months-old wt mice. There was a
significantly higher expression in the RV and a higher
expression in comparison to mRNA in the RV of 3-
months-old wt mice. The ratio between TIMP-2:TIMP-
3:TIMP-4 was changed predominantly in the LV of
3-months-old tg mice in comparison to wt controls
(Tab. 1). This change was characterized by a significantly
increased TIMP-4 mRNA expression in the LV of 3
Briest/Homagk/Baba/Deten/Raßler/Tannapfel/Wagner/Wenger/ZimmerCell Physiol Biochem 2004;14:277-284
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Fig. 4. A) Relative abundance of MMP-2 (filled bars)
and MMP-9 (open bars) activity in the LV of wt and tg
mice at 3 and 7 months of age obtained from zymography.
Band intensities were compared with the protein
concentration. B) TIMP-4 mRNA expression in the LV
(filled bars) and RV (open bars) in tg mice in comparison
to wt mice. RNA was subjected to RNase protection
assay. All data are expressed as per cent of time-
corresponding wt. Means ± S.E.M.; * P < 0.05 vs. the
time-corresponding wt; † P < 0.05 vs. MMP-9; number
of measurements in parentheses (first for MMP-2/second
for MMP-9 in A, and first for LV/second for RV in B).
Table 1. Cardiac
mRNA expression
of matrix metallo-
proteinase (MMP)
-2 and its tissue
inhibitors (TIMP)
-2, -3 and -4 in the
left (LV) and right
ventricle (RV) of
transgenic (tg)
mice overexpres-
sing the human
e r y t h r o p o i e t i n
gene in com-
parison to wild
type mice (wt).
months old tg mice (Fig. 4B). The predominant TIMP in
cardiac tissue was TIMP-3 in 7-months-old wt and tg
mice in LV as well as in RV (Tab. 1).
The hypertrophy of the tg-heart was not
accompanied by an increase of Sirius red-detectable
collagen deposition. In the LV, the interstitial collagen
content was 0.28 ± 0.03% in wt mice and 0.30 ± 0.03%
in tg mice; in the RV, it was 0.35 ± 0.05% in wt and 0.38
± 0.06% in tg animals (p > 0.05, n = 5 in wt and tg,
respectively, results from Sirius red staining, data not
shown).
Lung
The relative lung weight was increased in 7-months-
old tg mice (Fig. 5A). However, this increase was not
accompanied by an elevated wet-to-dry weight ratio of
the lung (wt: 4.16 ± 0.03%, n = 4; tg: 4.49 ± 0.14%, n = 5;
p > 0.05). There was slight edema but pronounced
hemorrhage (Fig. 5D) without iron deposition (iron staining,
data not shown). The interalveolar septa had a greater
thickness in 7-month-old tg animals (Fig. 5D). This was
accompanied by interstitial and perivascular fibrosis,
indicated by elevated deposition of collagen I (Fig. 5E),
collagen III and IV (data not shown).
Liver
The relative liver weight was also increased in tg
mice (Fig. 6A). The liver of 7-months-old tg mice was
characterized by hemorrhage (Fig. 6D) with iron
deposition (data not shown) and by thickening of the vessel
wall (Fig. 6D), which was accompanied by perivascular
and interstitial fibrosis. There was more collagen I (Fig.
6E), collagen III and collagen IV (data not shown) in the
interstitial and perivascular space in 7-month-old tg mice.
Values are mean ± S.E.M.;* P < 0.05 vs. time corresponding wt.; † P < 0.05 vs. LV; ‡ P < 0.05 vs. corresponding 3 months results
†‡
Erythrocytosis induced cardiac remodeling Cell Physiol Biochem 2004;14:277-284
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Fig. 6. Liver weight/body weight ratio (LiW/BW) in wild type
(wt) and transgenic (tg) mice after 3 and 7 months. A) Results
are expressed as per cent of time-corresponding wt. Means ±
S.E.M.; * P < 0.05 vs. the time-corresponding wt; number of
measurements in parentheses. Histological changes (B-E) in tg
mice in comparison to wt in consecutive slices. Representative
hematoxylin-eosin staining of 7 months old wt (B) and tg (D)
mice. Representative immunohistochemical staining of collagen
I of 7 months old wt (C) and tg (E) animals. After immunostaining,
the slices were counterstained with hematoxylin (original
magnification 20x).
Fig. 5. Lung weight/body weight ratio (LuW/BW) in wild type
(wt) and transgenic (tg) mice after 3 and 7 months. A) Results
are expressed as per cent of time-corresponding wt. Means ±
S.E.M.; * P < 0.05 vs. the time-corresponding wt; number of
measurements in parentheses. Histological changes (B-E) in tg
mice in comparison to wt in consecutive slices. Representative
hematoxylin-eosin staining of 7 months old wt (B) and tg (D)
mice. Representative immunohistochemical staining of collagen
I of 7 months old wt (C) and tg (E) animals. After immunostaining,
the slices were counterstained with hematoxylin (original
magnification 28x).
Discussion
Erythrocytosis induced an increase of the heart
weight of both ventricles in 7 months old tg mice (Fig.
1A). The hypertrophy of both ventricles (Fig. 1A) was
accompanied by an elevation of LV BNP production (Fig.
1B). Brain natriuretic peptide (BNP), the more ventricle-
specific natriuretic peptide is elevated in cardiac
hypertrophy and was described as an “emergency”
cardiac hormone against ventricular overload [16]. It has
been shown that central venous pressure was elevated
in EPO-tg6 mice [9]. Cardiac hypertrophy in 8 months
old tg6 mice was also documented at the histological level
by an increase of myocyte cross sectional area from 495
± 32 to 644 ± 49 µm2 (p < 0.05) [10]. In contrast, in rats
in which the hematocrit was raised to 0.63 by EPO
administration, no hypertrophy of the RV or LV was
observed [17, 18]. However, moderate RV hypertrophy
without LV hypertrophy had occurred after i.p. injection
of packed red cells into mice [19, 20]. The hematocrit
had been increased to 0.67-0.80. The hematocrit of 0.63
apparently is not high enough to induce cardiac
hypertrophy. Increased hematocrit induces RV
hypertrophy and hematocrit of 0.80 and higher induces
hypertrophy of both ventricles.
The erytrocytosis-induced hypertrophy of the heart
was accompanied by a change in the composition of the
main components of the ECM, collagen I and III. There
Briest/Homagk/Baba/Deten/Raßler/Tannapfel/Wagner/Wenger/ZimmerCell Physiol Biochem 2004;14:277-284
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was an age-dependent decrease in the mRNA expression
of both collagens in the RV (Fig. 2). The expression of
collagen III was changed to a lower expression and that
of collagen I to a higher expression in tg mice, thus resulting
in a relative elevation of the collagen I portion, especially
in the LV of tg mice. There was more collagen III than
collagen I in 3-months-old wt and tg mice as shown by
the collagen type I to type III ratio of around 0.8 (Fig.
2C). The collagen type I to type III ratio was elevated to
1.4 in the LV of 7-months-old tg mice (Fig. 2C). This
elevated collagen I mRNA content in the ECM could
have been responsible for a higher stiffness of this
ventricle, since collagen I is not as elastic as collagen III
[21].
The lack of overt fibrosis in erythrocytosis-induced
hypertrophy can be explained by the fact that the
concentration of collagen is not greater in volume overload
hypertrophic hearts [22]. A higher cross-linking rate was
postulated, since there was a rise in the activity of lysyl
oxidase, which is the enzyme responsible for initiating
the formation of cross-links in collagen. The decrease of
the relaxation time index of the LV from 2.66 ± 0.11 in
wt mice to 2.23 ± 0.14 (p < 0.05) [10] could be a result of
the stiffer LV. Nevertheless, the baseline heart function
of tg6 mice was not significantly different from wt mice
apart from a decreased pressure amplitude in the aorta
(wt: 26.6 ± 1.3, tg: 22.1 ± 0.9 mmHg, p < 0.05, [10]) and
an increased central venous pressure (wt: 0, tg: 3 ± 2
mmHg, p < 0.05, [9]) in tg6 mice. However, tg6 mice had
a reduced exercise performance [9]. If the mechanism
of norepinephrine-stimulation is similar to that of reduced
exercise performance in tg6 mice, then myocardial
ischemia and ultimately acute heart failure is a typical
feature [10].
There was a good correlation between BNP and
the expression of collagen I in the LV (Abb. 3). This
supports the significance of the relative elevation of
collagen I expression in tg mice. This correlation can also
be explained in the light of the known antifibrotic
properties of BNP [23]. Focal fibrotic lesions were
observed in ventricles from BNP-/- mice with a
remarkable increase in ventricular mRNA expression of
collagen I, which is implicated in the generation and
progression of ventricular fibrosis. High mRNA levels of
collagen I in EPO-tg6 mice might be responsible for the
increased expression of BNP which in turn may prevent
the deposition of collagen and thus fibrosis. This balance
could have been responsible for the lack of interstitial
fibrosis in older tg mice.
Tissue inhibitors of metalloproteinases (TIMPs)
comprise a family of four distinct, but structurally and
functionally similar proteins that (together with the
MMP’s) regulate the extracellular matrix in a variety of
tissues and can lead to remodeling [24]. The most recently
described member, TIMP-4 is the most cardiospecific
[25, 24] and forms complexes with pro MMP-9 and MMP-
2 [26]. Therefore, elevated TIMP-4 expression (Fig. 4B)
could explain the change of MMP gelatinolytic activity
from MMP-9 to MMP-2 in the LV of 3-months-old tg
mice (Fig. 4A). TIMP-4 seems to have a higher potency
to inhibit MMP-9 activity than to inhibit MMP-2 activity
since the higher level of complexed TIMP-4 in sham-
operated dogs was accompanied by lower MMP-9 activity
in comparison to pacing-induced atrial cardiomyopathy
[27]. The elevated expression of TIMP-4 only in the LV
of 3 months old tg mice (Fig. 4B) which resulted in
significant changes of the ratio between TIMP-2, -3 and
-4 (Tab. 1) and a shift of MMP activity to MMP-2 (Fig.
4A) seems to be a sign for an early remodeling process
of the ECM. The reason for the altered ratio between
TIMP-2, -3 and -4 in the RV of 7 months old tg mice
(Tab. 1) could probably be explained by a different nature
of ECM remodeling in the RV, since TIMP-3 was more
pronounced.
The increased lung weight (Fig. 5A) in combination
with hemorrhage, thickening of interalveolar septa (Fig.
5D) and especially interstitial fibrosis (Fig. 5E) in 7-months-
old tg mice may be an indication that there was an
intermittent LV insufficiency. This appears to be a relative
cardiac insufficiency which becomes manifest only when
the animals are subjected to exercise [9] or NE infusion
[10].
Also liver showed signs of hemorrhage (Fig. 6D)
and was characterized by interstitial and perivascular
fibrosis (Fig. 6E), with an increase of the relative liver
weight in tg animals (Fig. 6A). The increase was not so
pronounced as in lung. However, this might also be the
result of relative RV insufficiency which was not as
pronounced as in the LV.
In conclusion, the present study demonstrates that
in chronic erythrocytosis there was remodeling of the heart
with development of hypertrophy and alteration in the
composition of the ECM in mice overexpressing EPO.
Increased MMP-9 and decreased MMP-2 activity could
be induced by elevated TIMP-4 expression in the LV of
3-months-old tg mice, followed by a shift of collagen
mRNA expression from type III to type I in this ventricle
without a change in the amount of interstitial collagen
content in 7-months-old tg animals. The shift to collagen
I might be associated with a stiffer ventricle and thus
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lead to diastolic dysfunction. This could be responsible
for a relative and intermittent LV and RV insufficiency,
which in the long run leads to elevation of lung and liver
weight with hemorrhage and interstitial fibrosis.
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